A Review of Epidermal Growth Factor Receptor/HER2 Inhibitors in the Treatment of Patients With Non-Small-Cell Lung Cancer
Lung Carcinogenicity of Sulfur Mustard
Oxaliplatin in First-line Therapy for Advanced Non-Small-Cell Lung Cancer
Initial Experience With Endobronchial Ultrasound in an Academic Thoracic Surgery Program
Response to Pemetrexed Chemotherapy in Lung Adenocarcinoma-Bronchioloalveolar Carcinoma Insensitive to Erlotinib
Carboplatin Plus Pemetrexed as First-line Treatment of Patients With Malignant Pleural Mesothelioma
Plasma Nucleosome Levels Might Predict Response to Therapy in Patients With Advanced Non-Small-Cell Lung Cancer
Concurrent Chemoradiation Therapy With Docetaxel/Cisplatin Followed by Docetaxel Consolidation Therapy in Inoperable Stage IIIA/B Non-Small-Cell Lung Cancer
Subsequent Chemotherapy Improves Survival Outcome in Advanced Non-Small-Cell Lung Cancer With Acquired Tyrosine Kinase Inhibitor Resistance
Clinical Trials List